Which intervention has the STRONGEST evidence for reducing the risk of cardiovascular events in a patient with type 2 diabetes and established atherosclerotic cardiovascular disease?
-
A
Adding an SGLT2 inhibitor or GLP-1 receptor agonist with proven cardiovascular benefit
-
B
Intensifying statin therapy to achieve LDL < 50 mg/dL
-
C
Targeting HbA1c < 6.0% to minimize glucose toxicity
-
D
Adding aspirin 325 mg daily regardless of bleeding risk